Biodexa Pharmaceuticals (NASDAQ: BDRX) has announced the promotion of Fiona Sharp to chief financial officer (CFO) and company secretary—in addition to her election to the board of directors—effective immediately.
The company also announced that Stephen Stamp will relinquish his roles as CFO and company secretary, but will remain as CEO.
Before joining Biodexa, Ms. Sharp was assistant director of finance for the Hywel Dda University Health Board.
In a statement, Dr. Stephen Parker, chairman of Biodexa, commented, “In the six years she has been with us, Fiona has made very significant contributions to the financial governance of the group, sometimes in extremely challenging circumstances. This promotion is well-deserved and the other directors and I are looking forward to working alongside Fiona on the Biodexa Board”.
